Bacterial Community of the Digestive Tract of the European Medicinal Leech (Hirudo verbana) from the Danube River

The digestive tract of medicinal leeches from commercial suppliers has been investigated previously and comprises of a relatively simple bacterial community. However, the microbiome of medicinal leeches collected directly from the natural habitat has not been examined. In this study, we characterized the bacterial community in the digestive tract (anterior crop, posterior crop, and intestine) of the European medicinal leech, Hirudo verbana, collected from the Danube river using culture-independent and culture-dependent approaches. Culture-independent approach confirmed that the digestive tract of H. verbana carries a relatively simple bacterial community with species richness in the individual samples ranging from 43 to164. The dominant bacterial taxon was Mucinivorans sp. (49.7% of total reads), followed by Aeromonas sp. (18.7% of total reads). Several low abundance taxa, new for H. verbana, such as Phreatobacter, Taibaiella, Fluviicola, Aquabacterium, Burkholderia, Hydrogenophaga, Wolinella, and unidentified Chitinophagia, were also detected. The aerobic culturing approach showed Aeromonas veronii (Proteobacteria), the known leech symbiont, as the most dominant taxon followed by several Pseudomonas and Acidovorax spp. No significant differences in the bacterial community composition were detected among different parts of the digestive tract of individual leeches. However, the overall composition of the bacterial community among individual specimen varied significantly and this is possibly due to differences in leech age, feeding status, and blood source. Our results showed that the core bacterial community of H. verbana collected from the natural habitat is similar to that reported from the digestive tract of commercially supplied leeches maintained in the laboratory.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Characterizing the digestive tract microbiome of wild Hirudo verbana from the Danube, this study using culture-dependent and culture-independent approaches found Mucinivorans sp. dominant (49.7% of reads) followed by Aeromonas sp. (18.7%), with a core community similar to commercially supplied leeches.

Explore how this research connects to clinical practice

More peer-reviewed studies in Safety & Infection Control.

• Improvement of patient care through hirudotherapy and the management of leeches from their reception to their disposal in France — Vaesken C et al. (2023)
• Hirudotherapy (medicinal leeches) for treatment of upper airway obstruction in a dog — Trenholme H, Masseau I, Reinero C (2021)
• Analysis of antibiotic resistant infections associated with hirudotherapy — Brauer P et al. (2024)
• Kounis syndrome due to hirudotherapy (leech therapy) in emergency department; a case report — Çakmak T et al. (2018)
• Complications of leech therapy — Pourrahimi M, Abdi M, Ghods R (2020)
• Medicinal leech therapy and Aeromonas spp. infection — Verriere B et al. (2016)
• Rethinking antimicrobial prophylaxis in patients receiving medicinal leech therapy — McCracken J, Koehler S, Sharma R (2022)
• Prophylactic use of levofloxacin during medicinal leech therapy — Bauters T et al. (2014)
• Leech Application-related Upper Gastrointestinal Bleeding: A Case Report — Dolek U et al. (2023)
• A clinical trial for evaluation of leech application in the management of Vicarcikā (Eczema) — Shankar K et al. (2014)

Browse all ASH-analysed research →